Immunodeficiency Clinical Trials in Paris, Paris
2 recruitingParis, Paris, France
Showing 1–2 of 2 trials
Recruiting
Phase 2
OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients: a Randomized Factorial Controlled Strategy Trial
COVID-19Immunodeficiency
ANRS, Emerging Infectious Diseases256 enrolled18 locationsNCT05587894
Recruiting
Phase 2
A Study to Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases
LeiomyosarcomaSolid Organ Transplant ComplicationsLymphoproliferative Disorders+8 more
Pierre Fabre Medicament190 enrolled40 locationsNCT04554914